Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers.
Srivastava P, Wang T, Clark BZ, Yu J, Fine JL, Villatoro TM, Carter GJ, Brufsky AM, Gorantla VC, Huggins-Puhalla SL, Emens LA, Basili T, da Silva EM, Reis-Filho JS, Bhargava R.
Srivastava P, et al.
NPJ Breast Cancer. 2022 Apr 20;8(1):51. doi: 10.1038/s41523-022-00415-z.
NPJ Breast Cancer. 2022.
PMID: 35444182
Free PMC article.